1. Home
  2. NTHI vs BEEP Comparison

NTHI vs BEEP Comparison

Compare NTHI & BEEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • BEEP
  • Stock Information
  • Founded
  • NTHI 2008
  • BEEP 2015
  • Country
  • NTHI United States
  • BEEP United States
  • Employees
  • NTHI N/A
  • BEEP N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • BEEP Blank Checks
  • Sector
  • NTHI Health Care
  • BEEP Finance
  • Exchange
  • NTHI Nasdaq
  • BEEP Nasdaq
  • Market Cap
  • NTHI 142.5M
  • BEEP 162.0M
  • IPO Year
  • NTHI N/A
  • BEEP N/A
  • Fundamental
  • Price
  • NTHI $5.83
  • BEEP $4.59
  • Analyst Decision
  • NTHI
  • BEEP Strong Buy
  • Analyst Count
  • NTHI 0
  • BEEP 2
  • Target Price
  • NTHI N/A
  • BEEP $6.75
  • AVG Volume (30 Days)
  • NTHI 54.1K
  • BEEP 115.5K
  • Earning Date
  • NTHI 01-01-0001
  • BEEP 08-12-2025
  • Dividend Yield
  • NTHI N/A
  • BEEP N/A
  • EPS Growth
  • NTHI N/A
  • BEEP N/A
  • EPS
  • NTHI N/A
  • BEEP N/A
  • Revenue
  • NTHI $79,990.00
  • BEEP $36,416,000.00
  • Revenue This Year
  • NTHI N/A
  • BEEP $5.22
  • Revenue Next Year
  • NTHI N/A
  • BEEP $5.13
  • P/E Ratio
  • NTHI N/A
  • BEEP N/A
  • Revenue Growth
  • NTHI 13.52
  • BEEP 13.81
  • 52 Week Low
  • NTHI $3.20
  • BEEP $2.48
  • 52 Week High
  • NTHI $25.00
  • BEEP $4.86
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • BEEP 70.23
  • Support Level
  • NTHI N/A
  • BEEP $3.95
  • Resistance Level
  • NTHI N/A
  • BEEP $4.66
  • Average True Range (ATR)
  • NTHI 0.00
  • BEEP 0.25
  • MACD
  • NTHI 0.00
  • BEEP 0.06
  • Stochastic Oscillator
  • NTHI 0.00
  • BEEP 91.21

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About BEEP Mobile Infrastructure Corporation

Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. It operates in a single reportable segment: parking. The company derives majority of revenue from Percentage rental income.

Share on Social Networks: